CONTENT

Destacados

HIVACAT

Bonaventura Clotet welcomes students of the new edition of the Master in AIDS pathogenesis and treatment

24/09/2013

  • The Master in AIDS pathogenesis and treatment provides a broad view of the field of virology and immunology, and explores in depth the antiretroviral treatment and the paths for virus eradication.
  • The program is organized by the Institute for AIDS Research IrsiCaixa in collaboration with the Universitat Autònoma de Barcelona (UAB) and the Escola Universitària d’Infermeria i Fisioteràpia Gimbernat.
  • The master classes of the program with internationally recognised researchersare open to the public and they will be complemented with a Visiting Student Program in some of the most important research centres in the USA such as the Ragon Institute (MGH, MIT and Harvard University) and the Section of Retroviral Therapeutics of the Brigham and Women’s Hospital (Harvard Medical School).
  • From September to June, students will also do an internship in one of the research groups of IrsiCaixa.

The coordinator of the Master in AIDS pathogenesis and treatment, Bonaventura Clotet, director of the Institute for AIDS Research IrsiCaixa, welcomed yesterday the students of the third edition of this program, organized jointly IrsiCaixa in collaboration with the Universitat Autònoma de Barcelona (UAB) and the Escola Universitària d’Infermeria i Fisioteràpia Gimbernat.

From September 2013 to June 2014, the University Master in AIDS pathogenesis and treatment will provide students a broad view of the field of virology and immunology, exploring in depth the antiretroviral treatment and the paths for virus eradication. Furthermore, it will give special emphasis on other retrovirus and their potential implications in different human pathologies.

An international program of excellence
The program is structured in seven modules led by senior researchers from IrsiCaixa. The theoretical lectures are given by researchers at IrsiCaixa, at the Germans Trias Hospital and at the Universitat Autònoma de Barcelona, and are complemented with master classes with internationally recognised researchers on HIV/AIDS from all over the world. This year, these sessions will be open to the public (more information: @IrsiCaixa and www.irsicaixa.es). In addition, students will also do an internship in one of the research groups of IrsiCaixa, in order to apply the research methodologies studied in the different modules.

With the main aim of providing a global vision and offering students with an updated knowledge on the research activities related to HIV; the program also integrates a module that pretends to announce the different research areas of some of the most important USA research centres including a Visiting Student Program that will take place in those centres. Thus, the master is conceived with the collaboration of the Ragon Institute (MGH, MIT and Harvard University), the Section of Retroviral Therapeutics of the Brigham and Women’s Hospital (Harvard Medical School), the Leonard M. Miller School of Medicine (University of Miami) and the Center for AIDS Research (University of California San Diego). The coordination of the master also offers the possibility to carry out the internship in one of these centers.

The master also encloses the topic on knowledge translation of research findings by including concepts such as knowledge economy, patents, data protection, intellectual property rights, etc. The company Esteve, has been involved on the definition and development of this topic within the Master’s program.


More information: Master in AIDS pathogenesis and treatment 2013/14 (PDF| 576KB)